Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Sumatriptan
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Generics=== Glaxo patents for sumatriptan expired in February 2009. At that time, Imitrex sold for about $25 a pill.<ref>{{cite web |title=GlaxoSmithKline sets out to dupe migraine sufferers with Treximet smoke and mirrors |date=24 April 2008 |publisher=Community Catalyst |url=https://www.communitycatalyst.org/blog/glaxosmithkline-sets-out-to-dupe-migraine-sufferers-with-treximet-smoke-and-mirrors-pal |access-date=22 March 2019}}</ref> [[Par Pharmaceutical]] then introduced generic versions of sumatriptan injection (sumatriptan succinate injection) 4- and 6-mg starter kits and 4- and 6-mg filled syringe cartridges, and 6-mg vials soon after.<ref>{{cite news |title = Par Pharmaceutical begins shipment of sumatriptan injection |url = http://www.parpharm.com/media/NR_20081106.jsp |archive-url = https://web.archive.org/web/20081210132734/http://www.parpharm.com/media/NR_20081106.jsp |url-status = dead |archive-date = 10 December 2008 |work = Par Pharmaceutical |date = 6 November 2008 |access-date = 25 November 2008 |df = dmy-all }}</ref> [[Mylan|Mylan Laboratories Inc.]], [[Ranbaxy Laboratories]], Sandoz (a subsidiary of [[Novartis]]), [[Dr. Reddy's Laboratories]], and other companies have been producing generic versions of sumatriptan tablets in 25-, 50-, and 100-mg doses. Generic forms of the drug are available in U.S. and European markets after Glaxo's patent protections expired in the respective countries. A nasal spray form of sumatriptan known as AVP-825 has been developed by Avanir and is generically available in some countries.<ref>{{cite news | vauthors = LaMattina J |title = If You 'Want To Make A Good Drug Great' Cost Must Be Factored In |url = https://www.forbes.com/sites/johnlamattina/2015/03/03/if-you-want-to-make-a-good-drug-great-cost-must-be-factored-in/ |access-date = 13 February 2017 |work = Forbes |date = 2 March 2015 |url-status = live |archive-url = https://web.archive.org/web/20170214105140/http://www.forbes.com/sites/johnlamattina/2015/03/03/if-you-want-to-make-a-good-drug-great-cost-must-be-factored-in/ |archive-date = 14 February 2017 |df = dmy-all }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)